Using IL-17 neutralizing antibodies can reduce serum alanine aminotransferase (ALT) levels and improve liver inflammation, which indicates that IL-17 plays an important regulatory role in the development of AIH (Zhao et al., 2011; Beringer and Miossec, 2018). The gene discussed is IL17A; the disease is Hepatitis.